CORPAY INC (CPAY)

US2199481068 - Common Stock

266.26  -0.15 (-0.06%)

After market: 266.26 0 (0%)

Fundamental Rating

6

Taking everything into account, CPAY scores 6 out of 10 in our fundamental rating. CPAY was compared to 102 industry peers in the Financial Services industry. CPAY scores excellent on profitability, but there are some minor concerns on its financial health. CPAY has a decent growth rate and is not valued too expensively.



8

1. Profitability

1.1 Basic Checks

CPAY had positive earnings in the past year.
CPAY had a positive operating cash flow in the past year.
CPAY had positive earnings in each of the past 5 years.
CPAY had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 6.30%, CPAY belongs to the top of the industry, outperforming 84.31% of the companies in the same industry.
CPAY has a better Return On Equity (30.63%) than 91.18% of its industry peers.
The Return On Invested Capital of CPAY (12.14%) is better than 90.20% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CPAY is significantly above the industry average of 7.18%.
Industry RankSector Rank
ROA 6.3%
ROE 30.63%
ROIC 12.14%
ROA(3y)6.46%
ROA(5y)6.6%
ROE(3y)32.25%
ROE(5y)28.37%
ROIC(3y)12.39%
ROIC(5y)11.79%

1.3 Margins

CPAY has a Profit Margin of 26.29%. This is amongst the best in the industry. CPAY outperforms 80.39% of its industry peers.
In the last couple of years the Profit Margin of CPAY has declined.
CPAY's Operating Margin of 44.28% is amongst the best of the industry. CPAY outperforms 86.27% of its industry peers.
In the last couple of years the Operating Margin of CPAY has remained more or less at the same level.
With an excellent Gross Margin value of 77.48%, CPAY belongs to the best of the industry, outperforming 84.31% of the companies in the same industry.
In the last couple of years the Gross Margin of CPAY has declined.
Industry RankSector Rank
OM 44.28%
PM (TTM) 26.29%
GM 77.48%
OM growth 3Y2.7%
OM growth 5Y-0.33%
PM growth 3Y-3.94%
PM growth 5Y-4.76%
GM growth 3YN/A
GM growth 5Y-4.8%

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CPAY is creating some value.
The number of shares outstanding for CPAY has been reduced compared to 1 year ago.
Compared to 5 years ago, CPAY has less shares outstanding
Compared to 1 year ago, CPAY has an improved debt to assets ratio.

2.2 Solvency

CPAY has an Altman-Z score of 2.26. This is not the best score and indicates that CPAY is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.26, CPAY is in the better half of the industry, outperforming 77.45% of the companies in the same industry.
CPAY has a debt to FCF ratio of 3.44. This is a good value and a sign of high solvency as CPAY would need 3.44 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.44, CPAY is in the better half of the industry, outperforming 67.65% of the companies in the same industry.
A Debt/Equity ratio of 1.93 is on the high side and indicates that CPAY has dependencies on debt financing.
CPAY has a Debt to Equity ratio of 1.93. This is in the lower half of the industry: CPAY underperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.93
Debt/FCF 3.44
Altman-Z 2.26
ROIC/WACC1.54
WACC7.89%

2.3 Liquidity

CPAY has a Current Ratio of 1.07. This is a normal value and indicates that CPAY is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.07, CPAY is in line with its industry, outperforming 47.06% of the companies in the same industry.
A Quick Ratio of 1.07 indicates that CPAY should not have too much problems paying its short term obligations.
CPAY has a Quick ratio (1.07) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 1.07

6

3. Growth

3.1 Past

CPAY shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.97%.
Measured over the past years, CPAY shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.95% on average per year.
CPAY shows a small growth in Revenue. In the last year, the Revenue has grown by 7.13%.
CPAY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.08% yearly.
EPS 1Y (TTM)5.97%
EPS 3Y15.12%
EPS 5Y9.95%
EPS Q2Q%7.89%
Revenue 1Y (TTM)7.13%
Revenue growth 3Y16.3%
Revenue growth 5Y9.08%
Sales Q2Q%3.77%

3.2 Future

CPAY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.72% yearly.
The Revenue is expected to grow by 8.36% on average over the next years. This is quite good.
EPS Next Y14.54%
EPS Next 2Y15.65%
EPS Next 3Y16%
EPS Next 5Y15.72%
Revenue Next Year5.82%
Revenue Next 2Y7.72%
Revenue Next 3Y8.49%
Revenue Next 5Y8.36%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.46, CPAY is valued correctly.
CPAY's Price/Earnings is on the same level as the industry average.
CPAY is valuated rather cheaply when we compare the Price/Earnings ratio to 28.16, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 11.77, which indicates a very decent valuation of CPAY.
CPAY's Price/Forward Earnings ratio is in line with the industry average.
CPAY's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.02.
Industry RankSector Rank
PE 15.46
Fwd PE 11.77

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CPAY is valued a bit cheaper than 68.63% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CPAY is valued a bit cheaper than 70.59% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.52
EV/EBITDA 11.28

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CPAY has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CPAY's earnings are expected to grow with 16.00% in the coming years.
PEG (NY)1.06
PEG (5Y)1.55
EPS Next 2Y15.65%
EPS Next 3Y16%

0

5. Dividend

5.1 Amount

No dividends for CPAY!.
Industry RankSector Rank
Dividend Yield N/A

CORPAY INC

NYSE:CPAY (7/1/2024, 7:26:00 PM)

After market: 266.26 0 (0%)

266.26

-0.15 (-0.06%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap18.71B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 15.46
Fwd PE 11.77
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.06
PEG (5Y)1.55
Profitability
Industry RankSector Rank
ROA 6.3%
ROE 30.63%
ROCE
ROIC
ROICexc
ROICexgc
OM 44.28%
PM (TTM) 26.29%
GM 77.48%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 1.93
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.07
Quick Ratio 1.07
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)5.97%
EPS 3Y15.12%
EPS 5Y
EPS Q2Q%
EPS Next Y14.54%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)7.13%
Revenue growth 3Y16.3%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y